In addition:
SMFM conference coverage
Highlights from this year's 42nd Annual Pregnancy Meeting.
Legally Speaking
How important are the experts?
Spotlight
About
News
CME/CE
Subscribe
Editorial Board
Partnerships
In this issue: Adnexal torsion, abnormal uterine bleeding, and endometriosis awareness month
Take a look beyond the cover of Contemporary OB/GYN®'s March issue.
Which article was your favorite? Let us know on Twitter with the hashtag #contemporaryobgyn!
Adnexal torsion requires careful diagnosis, management
Torsion of adnexal structures can occur in pregnant women, women post-hysterectomy, and postmenopausal women.
Understanding abnormal uterine bleeding in adolescents
Experts take a look at 2 cases to understand abnormal uterine bleeding in adolescents and provide a useful screening tool.
Celebrating Laura E. Riley, MD
Among other things, March is Women’s History Month, giving us an opportunity to acknowledge and appreciate the contributions women have made to society at large while enhancing their own lives.
Bringing awareness to endometriosis
National awareness months and days span a variety of topics, from celebrated foods (think National Ice Cream Day, National Bagel Day, National Pizza Day) to businesses (free Slurpee at 7-Eleven) to our terrain: health issues. March alone is a national health awareness month for over 10 conditions, one of which is endometriosis.
Provider bias in contraceptive counseling
Provider bias—stereotyped and prejudiced assumptions about patients and their “best interests”—can limit patient autonomy and informed decision-making, amplify medical distrust, and deter patients from seeking care. Such bias is often amplified when patients are young, low-income, and/or Black, Indigenous, or people of color (BIPOC).
Are race, ethnicity, menopause status linked to GI symptoms?
Being Non-Hispanic (N-H) Asian is a significant influencing factor for the number of gastrointestinal (GI) symptoms and the severity scores of GI symptoms, according to a study of 4 major racial/ethnic groups of midlife women in the United States.
Patient perspectives on vulvovaginal candidiasis
Among women with vulvovaginal candidiasis (VVC) or recurrent VVC (RVVC), the 3 most common signs and symptoms are itching (91.2%), burning (68.3%), and redness (58.1%), according to an online patient survey in BMC Womens Health.
Self-managing pelvic pain via the internet
A survey in the American Journal of Obstetrics & Gynecology revealed that patients with chronic gynecologic pain were twice as likely to use social media to understand or manage their condition than those without pain, at 37.8% vs 19.7% respectively.
Prenatal genetic data sharing and privacy risks
An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.
Pipeline News
Contemporary OB/GYN® sat down with Jessica Shim, MD, an attending in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital and Harvard Medical School to discuss Myfembree (relugolix, estradiol, and norethindrone acetate; Myovant Sciences, Pfizer) and its potential approval in May 2022. If approved, Myfembree could be game-changing for women with moderate to severe endometriosis-associated pain.
Articles in this issue
Delayed diagnosis of a bowel injury at laparoscopy
In this issue: Adnexal torsion, abnormal uterine bleeding, and endometriosis awareness month
Understanding abnormal uterine bleeding in adolescents
Adnexal torsion requires careful diagnosis, management
Bringing awareness to endometriosis
Celebrating Laura E. Riley, MD
Women with pelvic pain turn to social media for condition information, management
Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents
Prenatal genetic data sharing and privacy risks
Patient perspectives on vulvovaginal candidiasis
Provider bias in contraceptive counseling
Are race, ethnicity, and menopausal status associated with GI symptoms?
Recent Videos
Related Content
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024Article
A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024Article
A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
